One you might expect, one you might not expect
Recent studies have suggested the potential benefits of SGLT2 inhibitors, including empagliflozin, in slowing the progression of chronic kidney disease (CKD) in patients with type 2 diabetes, and reducing the risk of cardiovascular events.The decision to use empagliflozin in CKD should be made on a case-by-case basis, considering the patients overall kidney function and potential risks
Overbilling units whether through misapplication of the rounding rule or transcription error is a compliance risk
They are not intended to diagnose, treat, cure, or prevent any disease, and are not approved for human or animal administration
Sometimes, but spicy foods can aggravate reflux or nausea in people who are already more prone to GI symptoms on these medications
They required a stabilization method that would isolate the copper ions while maintaining their bioactivity